Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy.
Rettl R, Mann C, Duca F, Dachs TM, Binder C, Ligios LC, Schrutka L, Dalos D, Koschutnik M, Donà C, Kammerlander A, Beitzke D, Loewe C, Charwat-Resl S, Hengstenberg C, Kastner J, Eslam RB, Bonderman D.
Rettl R, et al. Among authors: dalos d.
Eur Heart J Cardiovasc Imaging. 2022 Jun 1;23(6):767-780. doi: 10.1093/ehjci/jeab226.
Eur Heart J Cardiovasc Imaging. 2022.
PMID: 34788394